ArticleJournal of hematology & oncology2020

DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.

Yonghan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.